Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: A population-based retrospective cohort study

Retina

Volumn 35, Issue 2, 2015, Pages 231-237

  Chen, San Ni ^a,b,f   Lian, Iebin ^c   Chen, Yi Chiao ^c   Ho, Jau Der ^d,e  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

central serous chorioretinopathy; Helicobacter pylori; peptic ulcer; population based cohort study

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; RETROSPECTIVE STUDY; RISK FACTOR; AGE DISTRIBUTION; CENTRAL SEROUS CHORIORETINOPATHY; FACTUAL DATABASE; MIDDLE AGED; TAIWAN;

ADULT; AGE DISTRIBUTION; CENTRAL SEROUS CHORIORETINOPATHY; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; INCOME; MALE; MIDDLE AGED; PEPTIC ULCER; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84922399462     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000278     Document Type: Article

References (44)

1. Gass JDM. Stereoscopic Atlas of Macular Disease: Diagnosis and Treatment. 3rd ed. St. Louis, MO: Mosby; 1987:46-59.
2. Spaide RF, Goldbaum M, Wont DWK, et al. Serous detachment of the retina. Retina 2003;23:820-846.
3. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 1987;7:111-131.
4. Mansuetta CC, Mason JO III, Swanner J, et al. An association between central serous chorioretinopathy and gastroesophageal reflux disease. Am J Ophthalmol 2004;137:1096-1100.
5. Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, casecontrol study. Graefes Arch Clin Exp Ophthalmol 2004;242: 800-802.
6. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834-1837.
7. Gass JD, Slamovits TL, Fuller DG, et al. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992;110:1717-1722.
8. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-68.
9. Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy. A case control study. Ophthalmology 2004;111:244-249.
10. Chen SN, Chen YC, Lian I. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Br J Ophthalmol 2014;98:110-114.
11. Goodwin RD, Stein MB. Generalized anxiety disorder and peptic ulcer disease among adults in the United Stated. Psychosom Med 2002;64:862-866.
12. Tennant C, Goulston K, Langeluddecke P. Psychological correlates of gastric and duodenal ulcer disease. Psychol Med 1986;16:365-371.
13. Messer J, Reitman D, Sacks HS, et al. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 1983;309:21-24.
14. Alexander MT, Kufera JA. Butting Heads on Matched Cohort Analysis Using SAS Software. North East SAS Users Group Conference Proceedings; November 11-14, 2007; Baltimore, MD. Available at: http://nesug.org/Proceedings/nesug07/sa/ sa01.pdf. Accessed September 5, 2012.
15. Polat FR, Polat S. The effect of Helicobacter pylori on gastroesophageal reflux disease. JSLS 2012;16:260-263.
16. Giusti C. Central serous chorioretinopathy: a new extragastric manifestation of Helicobacter pylori?: analysis of a clinical case. Clin Ter 2001;152:393-397.
17. Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, et al. Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection. Arch Soc Esp Oftalmol 2008;83:177-182.
18. Casella AM, Berbel RF, Bressanim GL, et al. Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo) 2012;67: 1047-1052.
19. Rahbani-Nobar MB, Javadzadeh A, Ghojazadeh L, et al. The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis 2011;11:99-103.
20. Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 2004;63:524-527.
21. D'Elios MM, Andersen LP. Helicobacter pylori: inflammation, Immunity, and Vaccines. Helicobacter 2006;12:15-19.
22. Bohr UR, Annibale B, Franceschi F, et al. Extragastric manifestations of Helicobacter pylori infection-other helicobacters. Helicobacter 2007;12:45-53.
23. Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract 2013;99: 200-208.
24. Deng B, Li Y, Zhang Y, et al. Helicobacter Pylori Infection and lung cancer: a review of an emerging hypothesis. Carcinogenesis 2013;34:1189-1195.
25. Papagiannakis P, Michalopoulos C, Papalexi F, et al. The role of Helicobacter pylori infection in hematological disorders. Eur J Intern Med 2013;24:685-690.
26. Pietroiusti A, DiomediM, SilvestriniM, et al. Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-584.
27. Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinic-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009;202:535-542.
28. Iriz E, Cirak MY, Engin ED, et al. Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsied. Tex Heart Inst J 2008;35:130-135.
29. Levenstein S, Ackerman S, Kiecolt-Glaser JK, Dubois A. Stress and peptic ulcer disease. JAMA 1999;281:10-11.
30. Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987;144:46-50.
31. Friedman M, Byres SO, Diamant J, Rosenman RH. Plasma catecholamin response of coronary prone subjects (Type A) to a specific challenge. Metabolism 1975;24:205-210.
32. Williams RB Jr, Lane JD, Kuhn CM, et al. Type A behavior and elevated physiological neuroendocrine responses to cognitive tasks. Science 1982;218:483-485.
33. Garg SP, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962-964.
34. Arndt CF, Sari A, Ferri M, et al. Electrophysiological effects of corticosteroid on the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2001;42:472-475.
35. Boscaro M, Barzon L, Fallo F, Sonino N: Cushing's syndrome. Lancet 2001;357:783-791.
36. Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009;94:2743-2750.
37. Eren C, Nuhoglu I, Yilmaz M, et al. Blood coagulation and fibrinolysis in patients with Cushin's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activated fibrinolysis inhibitor levels. J Endocrinol Invest 2009;32: 169-174.
38. Dajani EZ, Agrawal NM. Prevention of nonsteroidal antiinflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dig Dis 1995;13:48-61.
39. Caccavale A, Romanazzi F, Imparato M, et al. Low-dose aspirin as treatment for central serous chorioretinopathy. Clin Ophthalmol 2010;4:899-903.
40. Caccavale A, Imparato M, Romanazzi F, et al. A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses 2009;73:435-437.
41. Hu CC, Ho JD, Lin HC. Retinal vein occlusion and the risk of acute myocardial infarction: a 3 year follow-up study. Br J Ophthalmol 2009;93:717-720.
42. Chou KT, Huang CC, Tsai DC. Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. Am J Ophthalmol 2012;154:200-205.
43. Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: a 5-year populationbased follow-up study. Stroke 2010;41:613-617.
44. Tsai DC, Huang CC, Chen SJ, et al. Central serous chorioretinopathy and risk of ischemic stroke: a population based cohort study. Br J Ophthalmol 2012;96:1484-1488.